Anti-adhesion and antiproliferative cellulose triacetate membrane for prevention of biomaterial-centred infections associated with Staphylococcus epidermidis.
The initial step in preventing biomaterial-associated infections consists of preventing bacterial adhesion to the device surface. One possible approach is the design of antibiotic-releasing biomaterials. Cellulose triacetate (CTA) membranes with the antibiotic imipenem (IPM) entrapped (CTA-IPM) were prepared. The material was characterised in terms of surface morphology by scanning electron microscopy, surface free energy of interaction and X-ray photoelectron spectroscopy (XPS). Antibiotic release studies were also performed. In vitro adhesion of Staphylococcus epidermidis RP62A to CTA-IPM was investigated using a modified microtitre plate assay, and the antibacterial activity of the CTA-IPM membrane was assessed by a modified Kirby-Bauer test, which showed effective entrapment of the antibiotic as confirmed by XPS and hydrophilicity assays. Release studies showed that this drug-polymer conjugate serves as an adequate reservoir for sustained release of IPM over a period of 71h at an effective bacteriostatic concentration. Moreover, bacterial adhesion tests showed a statistically significant decrease in the adhesion of S. epidermidis RP62A to CTA-IPM compared with its adhesion to CTA alone. The present innovative approach is capable of providing a membrane with anti-adhesive and antiproliferative properties, thus encouraging in vivo studies to provide a better simulation of the clinical situation.
Extremina
Clara I
CI
REQUIMTE, Faculdade de Farmácia, Universidade do Porto, Rua Aníbal Cunha 164, 4050-047 Porto, Portugal. extremina@gmail.com
Fonseca
A Freitas da
AF
Granja
Pedro L
PL
Fonseca
António P
AP
D000900:Anti-Bacterial Agents / Q000378:metabolism / Q000494:pharmacology*; D001422:Bacterial Adhesion / Q000187:drug effects*; D001672:Biocompatible Materials; D002482:Cellulose / Q000031:analogs & derivatives; D004864:Equipment and Supplies / Q000382:microbiology*; D006801:Humans; D015378:Imipenem / Q000378:metabolism / Q000494:pharmacology*; D008566:Membranes / Q000737:chemistry*; D008826:Microbial Sensitivity Tests; D016459:Prosthesis-Related Infections / Q000517:prevention & control*; D013212:Staphylococcus epidermidis / Q000187:drug effects* / Q000302:isolation & purification
D000900:Anti-Bacterial Agents; D001672:Biocompatible Materials; D015378:Imipenem; D002482:Cellulose; C024671:cellulose triacetate